Together, these findings underscore that high SSTR2 expression in HCC is associated with a proteomic landscape enriched for oncogenic signaling and markers of tumor progression, further supporting the hypothesis that SSTR2high tumors represent a biologically aggressive and clinically unfavorable subtype of HCC. This evidence concerns the gene SSTR2 and hepatocellular carcinoma.